MacroGenics Inc (NASDAQ:MGNX) shares fell 7.4% in premarket trading Tuesday after the company announced the FDA placed a partial clinical hold on its LINNET study of lorigerlimab in gynecologic cancer ...

The FDA has ordered MacroGenics to halt enrollment in a phase 2 trial of the biotech’s lead candidate lorigerlimab following severe side effects that led to one patient death.

Yelena Zhuk, a professor in the Radiology Department of Belarusian State Medical University, told the STV television channel ...

A blood sample does not have an obvious odor to a person in a lab coat. But to an electronic nose, it can carry a chemical signature that points toward disease.

USA News Group News Commentary, The global oncology market is on track to nearly triple in value over the next decade, growing from $279.98 billion in 2026 to an estimated $748.17 billion by 2035[1].

MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment ...

Daiichi Sankyo's upcoming AVANZAR study is critical for the stock, as success would unlock billions in revenue and accelerate growth plans. Read more on DSNKY here.

MacroGenics (MGNX) stock plunges as the FDA imposes a partial clinical hold on a mid-stage trial for the company's lead asset, lorigerlimab. Read more here.

Why are women at higher risk of developing cancer if they have chronic stress and anxiety issues? Doctor explains the hidden and often ignored risk factors of cancer in women. Read on to find out!

MacroGenics Inc. MGNX shares are down during Tuesday’s premarket session following the announcement of a partial clinical hold on its Phase 2 LINNET study. The stock’s decline comes as the company is ...

The global medical cyclotron market shows steady growth, expected to be valued at around US$246.8 million in 2026 and projected to reach US$405.4 million by 2033, with a CAGR of 5.4% during this ...

The global medical cyclotron market shows steady growth, expected to be valued at around US$246.8 million in 2026 and projected to reach US$405.4 million ...